MedTrace Logo

Flax Muffins and Cholesterol Lowering

NCT01821131 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2024-02-02

No results posted yet for this study

Summary

This Clinical Trial is being conducted to study the LDL (bad) cholesterol lowering abilities of flax. The purpose of this study is to find the lowest dose of flax that can lower LDL-cholesterol.

Conditions

  • Above Optimal Plasma LDL Concentrations

Interventions

OTHER

muffin

Sponsors & Collaborators

  • Agriculture and Agri-Food Canada

    collaborator OTHER_GOV

  • St. Boniface Hospital

    lead OTHER

Principal Investigators

  • Heather J Blewett, PhD · Agriculture and Agri-Food Canada

  • Thomas Wolever, PhD, MD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-11-30
Completion
2025-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01821131 on ClinicalTrials.gov